Product information

From Health Canada

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2021-11-25

Original market date: See footnote 1

2015-09-28

Product name:

PLIAGLIS

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

02398028

Product Monograph/Veterinary Labelling:

Date: 2021-11-22 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

SCIENCES DE LA PEAU CRESCITA INC. / CRESCITA SKIN SCIENCES INC.
2805 Place L-R. Renaud
Laval
Quebec
Canada H7V 0A3

Class:

Human

Dosage form(s):

Cream

Route(s) of administration:

Topical

Number of active ingredient(s):

2

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

72:00.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

N01BB52 LIDOCAINE, COMBINATIONS

Active ingredient group (AIG) number:See footnote5

0253490001

List of active ingredient(s)
Active ingredient(s) Strength
LIDOCAINE 7 %
TETRACAINE 7 %
Version 4.0.2
Date modified: